A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: A pediatric brain tumor consortium study

Authors

Maryam Fouladi
Clinton F. StewartFollow
Susan M. Blaney
Arzu Onar-Thomas
Paul Schaiquevich
Roger J. Packer, George Washington UniversityFollow
Stewart Goldman
J. Russell Geyer
Amar Gajjar, University of Tennessee
Larry E. Kun
James M. Boyett
Richard J. Gilbertson

Document Type

Journal Article

Publication Date

9-2013

Journal

Journal of Neurooncology

Volume

Volume 114, Issue 2

Inclusive Pages

173-179

APA Citation

Fouladi, M., Stewart, C.F., Blaney, S.M., Onar-Thomas, A., Schaiguevich, P., Packer, R.J., Goldman, S., Geyer, J.R., Gajjar, A., Kun, L.E., Boyett, J.M., Gilbertson, R.J. (2013). A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study. Journal of Neurooncology, 114(2), 173-179.

Peer Reviewed

1